- LATEST
- WEBSTORY
- TRENDING
BUSINESS
Mukesh Ambani’s Reliance might bring Rs 53,400 crore UK pharma company to India; give competition to Tata 1mg
Mukesh Ambani’s Reliance Industries Limited is closing in on acquiring a massive British pharmaceutical company, which can give tough competition to Ratan Tata’s Tata 1mg app.
Updated : Jul 05, 2023, 12:08 PM IST | Edited by : Vaishnawi Sinha
 "Mukesh Ambani’s Reliance might bring Rs 53,400 crore UK pharma company to India; give competition to Tata 1mg")
TRENDING NOW
)
Shilpa Shetty breaks down, Salman Khan cancels shoot; celebs rush to Lilavati hospital after Baba Siddique shot dead
)
Amid divorce rumours of Aishwarya, Abhishek Bachchan, video of Jaya announcing his engagement with Karisma goes viral
)
Bigg Boss 18: Rajat Dalal, Vivian Dsena, Avinash Mishra, Chahat Pandey, top 5 most popular contestants this week
)
Aishwarya Rai's biggest flop was rejected by Priyanka Chopra, ruined director's career, didn't earn even Rs 10 crore
)
Amaran box office collection day 4: Sivakarthikeyan-starrer becomes highest-grossing film in his career, earns Rs...
)
'Fake drama': Sania Mirza, Shoaib Malik celebrate their son Izhaan's birthday in Dubai; netizens troll Pak cricketer due
)
Aishwarya Rai fans express anger after Abhishek Bachchan, Amitabh Bachchan skip her birthday post: 'She needs to...'
)
Mukesh Ambani's superhit plan for Jio users: 2GB of daily data, unlimited calls, Netflix subscription for just Rs...
)
Meet IAS officer who cracked UPSC exam twice without coaching, became youngest IPS at 21, is Vikas Divyakirti's...
)
Pakistani TikTok star Minahil Malik reacts after leaked video with boyfriend goes viral, says, 'I'm done...'
)
Rinku Singh buys luxurious bungalow after being retained by KKR for Rs 13 crore, SEE pics
)
Mumbai-Ahmedabad bullet train: 8 hour journey in 180 minutes, construction of 12 river bridges complete between...
)
Gandii Baat, XXX show actress Aabha Paul looks stunning in sultry photos, sexy videos
)
Amid linkup rumours with Abhishek Bachchan, Nimrat Kaur drops Diwali photos with cryptic note: 'Mere ghar se...'
)
Amaran box office collection day 5: Sivakarthikeyan film beats lifetime earnings of Kamal Haasan's Indian 2, earns Rs...
Reliance Industries Limited, the massive business conglomerate headed by billionaire Mukesh Ambani, is always expanding its horizons to bring big international brands in India. This time, Mukesh Ambani is closing in on a deal with a massive UK pharmaceutical company called Walgreens Boots Alliance.
Walgreens Boots Alliance Inc is a major league, multi-billion dollar company centered in the United Kingdom, while Mukesh Ambani’s Reliance is making major moves to acquire the company and bring its drug stores and pharmaceutical business to India.
Mukesh Ambani-owned Reliance Industries is closing in on a deal with Walgreens Boots Alliance, set to acquire its international drugstore units and chemists. As quoted by Bloomberg, sources said that a whopping offer has been made by Ambani to the UK-based company.
As per Outlook and Economic Times reports, Mukesh Ambani’s RIL is forming a consortium with US-based private equity firm Apollo Global Management Inc to acquire the popular pharmaceutical chain Boots, based in Britain and US.
Ambani’s company has made a whopping deal with Walgreens to acquire its pharma brand Boots, which has put the company’s valuation at around USD 6.5 billion, which roughly translates to Rs 53,400 crore in Indian currency.
Walgreens has been struggling since the pharmaceutical business has expanded to online markets, and if Mukesh Ambani’s deal goes through, the UK company will retain a minor stake in their organization, while Reliance will have the majority of the control.
It is expected that if the Reliance-Walgreens deal is successful, Mukesh Ambani will be boosting profits by introducing the company in India and launching an online drug store, giving tough competition to rival apps like Rata Tata’s Tata 1mg and Apollo Pharmacy.
The offer was made by Mukesh Ambani last year and it is expected that Walgreens Boots will be taking a decision soon, adding yet another feather of foreign acquisitions in the billionaire’s cap.
